Trademark: 86560752
Word
VENCLEXTA
Status
Registered
Status Code
702
Status Date
Friday, April 14, 2023
Serial Number
86560752
Registration Number
5078740
Registration Date
Tuesday, November 8, 2016
Mark Type
4000
Filing Date
Wednesday, March 11, 2015
Published for Opposition
Tuesday, August 11, 2015

Trademark Owner History
AbbVie Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Apr 14, 2023
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Apr 14, 2023
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Apr 14, 2023
Case Assigned To Post Registration Paralegal
Oct 5, 2022
Teas Section 8 & 15 Received
Nov 8, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 8, 2016
Registered-Principal Register
Oct 5, 2016
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 4, 2016
Allowed Principal Register - Sou Accepted
Oct 4, 2016
Statement Of Use Processing Complete
Oct 4, 2016
Use Amendment Filed
Oct 4, 2016
Case Assigned To Intent To Use Paralegal
Sep 16, 2016
Teas Statement Of Use Received
Apr 1, 2016
Notice Of Approval Of Extension Request E-Mailed
Mar 30, 2016
Sou Extension 1 Granted
Mar 30, 2016
Sou Extension 1 Filed
Mar 30, 2016
Teas Extension Received
Oct 6, 2015
Noa E-Mailed - Sou Required From Applicant
Aug 11, 2015
Official Gazette Publication Confirmation E-Mailed
Aug 11, 2015
Published For Opposition
Jul 22, 2015
Notification Of Notice Of Publication E-Mailed
Jul 4, 2015
Law Office Publication Review Completed
Jul 2, 2015
Assigned To Lie
Jun 16, 2015
Approved For Pub - Principal Register
Jun 16, 2015
Assigned To Examiner
Mar 23, 2015
New Application Office Supplied Data Entered
Mar 14, 2015
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24